News & Updates
Showing Infectious Diseases articles
Showing

Early switching to long-acting CAB + RPV expands treatment options for people with HIV-1
Oral antiretroviral therapy (ART) has transformed HIV care, enabling durable virologic suppression and substantially reducing HIV-related morbidity and mortality. However, maintaining virologic suppression requires consistent adherence. In an interview with MIMS Doctor, Dr Thomas Chik, Specialist in Infectious Disease in Hong Kong, discussed how people living with HIV (PLHIV) who achieve HIV RNA <50 copies/mL with oral therapy can be switched early to long-acting cabotegravir plus rilpivirine (CAB + RPV LA), which improves adherence. This is suitable for a range of PLHIV, including those who are new to ART.

Asthma: No difference in pneumonia risk between budesonide and fluticasone users
A territory-wide retrospective study of >16,000 adult patients with moderate-to-severe asthma finds no difference in risk of pneumonia between budesonide and fluticasone propionate (FP) or fluticasone furoate (FF) users.

Infective endocarditis not uncommon in children with staphylococcal bacteraemia
In paediatric patients with Staphylococcus (S) aureus bacteraemia (SAB), 8.8 percent present with S. aureus endocarditis (SAE), a study has shown. Both SAE and SAB are associated with prolonged hospitalization and higher mortality rates.






